Profiel
Andreas Buchbender is currently working as a Portfolio Manager at Medical Strategy GmbH since 2023.
Previously, he worked as a Scientific Assistant at Max Planck Institut für Pflanzenzüchtungsforschung from 2011 to 2013.
Dr. Buchbender completed his undergraduate and graduate degrees at the University of Hannover in 2016 and 2017 respectively.
He obtained his doctorate degree from The Johannes Gutenberg University of Mainz in 2021.
Actieve functies van Andreas Buchbender
| Bedrijven | Functie | Begin |
|---|---|---|
Medical Strategy GmbH
 Medical Strategy GmbH Investment ManagersFinance Medical Strategy GmbH (MS) is an independent German healthcare investment advisory firm which was established in 1992. Located in Gräfelfing, the firm specializes in financial advisory services and the management of speciality funds focused on the healthcare sector. Their clients are primarily institutional investors, including asset management firms, insurance companies, banks and pensions funds, but also high-net worth individuals. | Analyst-Equity | 01-11-2020 |
Eerdere bekende functies van Andreas Buchbender
| Bedrijven | Functie | Einde |
|---|---|---|
| Max Planck Institut für Pflanzenzüchtungsforschung | Corporate Officer/Principal | 01-01-2013 |
Opleiding van Andreas Buchbender
| University of Hannover | Graduate Degree |
| The Johannes Gutenberg University of Mainz | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Medical Strategy GmbH
Medical Strategy GmbH Investment ManagersFinance Medical Strategy GmbH (MS) is an independent German healthcare investment advisory firm which was established in 1992. Located in Gräfelfing, the firm specializes in financial advisory services and the management of speciality funds focused on the healthcare sector. Their clients are primarily institutional investors, including asset management firms, insurance companies, banks and pensions funds, but also high-net worth individuals. | Finance |
